325 Hospital Drive, Suite 106 Glen Burnie, MD 21061 | Call or Text Us at (443) 430-2998
Services
Innovative Treatment Centers • Glen Burnie, MD
We offer a wide range of services to help you overcome mental disability and addiction. The journey to a more satisfying life begins here.
Psychotherapy + Counseling
Psychotherapy and counseling are both therapeutic approaches aimed at helping individuals manage and overcome psychological and emotional challenges. Psychotherapy involves a deeper exploration of a person’s thoughts, emotions, behaviors and underlying mental health processes.
Counseling focuses on providing guidance, support, and practical solutions for specific life challenges and transitions. Counselors can address relationship problems, grief, stress management, and personal improvement.
At Innovative Treatment Centers our therapists and counselors may involve various therapeutic modalities such as cognitive behavioral therapy, motivational interviewing, somatic tracking, grief counseling, humanistic therapy, dialectical behavior therapy to identify the root causes of problems and develop strategies for coping, healing, and personal growth.
Psychiatric Diagnostic Assessment + Medication Management
The purpose of a psychiatric assessment is to diagnose emotional, developmental, or behavioral conditions. The goals are to determine where a diagnosis is present that requires treatment, create a treatment plan, determine the need for medication management and intervention, collect data to support a diagnosis, and establish a care plan.
Innovative Treatment Centers will work side by side with you to formulate a plan that is tailored to your needs. The conditions we treat are:
- Depressive disorders
- Anxiety and obsessive-compulsive disorders
- ADHD and neurodevelopmental disorders
- Bipolar and other related mood disorders
- Post traumatic stress disorder and trauma
- Substance related and addictive disorders.
- Sexual addiction and other sexual related disorders
- Schizophrenia spectrum and other psychotic disorders
- Gender dysphoria and many other conditions
Innovative Treatment Centers fosters a safe and non-judgmental environment for our patients. Our therapists and mental health providers are kink-affirming and LGBTQ+ allies who share common goals of promoting acceptance, understanding, and well-being for individuals who may feel marginalized and stigmatized by mainstream society.
Psychiatric Evaluation for SCS + Bariatric Surgery
For spinal cord stimulator implantation, bariatric surgery, and other invasive procedures, having a mental health clearance is an important aspect of the preoperative evaluation process for surgery. This clearance is typically provided by a mental health professional such as psychologist, psychiatric nurse practitioner, licensed mental health social worker, or psychiatrist to assess the patient’s mental and emotional well-being in relation to surgery.
Purpose: The psychological assessment helps identify any preexisting mental health conditions that might impact the success of the surgery or the patient’s ability to cope with the changes of post-surgery. Your mental health professional will evaluate your history including past or current diagnoses of conditions such as depression, anxiety, eating disorders, or other relevant mental health issues. The assessment involves interviews, psychological tests, and questionnaires to gain a comprehensive understanding of the patient’s mental health.
Readiness: the mental health professional will assess the patient’s readiness for surgery from a psychological standpoint. This involves the patient’s understanding of the surgery, their motivations, expectations, and their ability to comply with the necessary post-operative lifestyle changes the procedure will impose.
Based on the assessment, the mental health professional will provide recommendations to the surgical team. If the patient is deemed psychologically suitable for the surgery and capable of managing the psychological aspects of the pre and post operative process, they will receive a mental health clearance to proceed with the surgery. In some cases, we may recommend ongoing therapy or counseling before and after surgery to support psychological well being during this transformative process.
ADHD + Neurocognitive Assessment
At Innovative Treatment Centers, we understand the profound impact that attention-deficit/hyperactivity disorder (ADHD) can have on individuals and their daily lives. Our ADHD + Neurocognitive Assessment service is designed to provide a comprehensive and insightful evaluation of ADHD, tailored to each patient's unique needs.
Our approach to ADHD assessment goes beyond the standard evaluations. We utilize cutting-edge neurocognitive assessment tools that offer a deeper understanding of how ADHD may be affecting cognitive functions, emotional well-being, and daily functioning. This assessment process helps us create personalized treatment plans, allowing us to address the core issues and provide the most effective interventions. Our team of experienced professionals is dedicated to delivering a thorough and compassionate evaluation, ensuring that every individual receives the attention and care they deserve. Whether you're seeking a first-time diagnosis or a reevaluation of your ADHD, Innovative Treatment Centers is committed to guiding you toward a brighter, more empowered future.
Don't let ADHD hold you back any longer. We aim to uncover the insights needed for a more accurate diagnosis and targeted treatment. We prioritize your well-being, striving to help you or your loved one achieve optimal functioning and an improved quality of life. Contact us today to schedule your assessment and take the first step towards a more fulfilling and focused future.
Addiction Medicine
The practitioners at Innovative Treatment Centers work with patients to help them overcome their dependencies, improve their overall health, and regain control over their lives.
Medications for Opioid Use Disorder (MOUD) is an approach to opioid use treatment that combines FDA-approved drugs with counseling and behavioral therapies. MOUD involves medications that target the brain, and psychosocial interventions such as counseling and skills development.
Common treatment options for MOUD include methadone, buprenorphine, and naltrexone. According to the National Institutes of Health (NIH), methadone and buprenorphine reduce the risk of death after opioid overdose. With MOUD, the relapse rate for those with OUD decreases to 50% at one year.
These treatments are most effective when someone is ready for them.
Conditions we treat:
- Opiate dependency and opiate use disorder (Heroin, fentanyl and other opioids)
- Alcohol use disorder
- Sedative hypnotic use disorder (benzodiazepines)
- Simulant use disorder
- Cannabis use disorder
- We screen and treat for Hepatitis C
Pain Reprocessing Therapy
Multiple studies have shown that chronic back pain, neck pain, fibromyalgia symptoms, repetitive strain injury, headaches, and other forms of chronic pain are often not the result of structural causes, but of psychophysiological processes that can be reversed. This is known as neuroplastic pain.
Pain is a danger signal. Normally when we injure ourselves, the body sends signals to the brain informing us of tissue damage, and we feel pain. But sometimes, the brain can make a mistake! Neuroplastic pain results from the brain misinterpreting safe messages from the body as if they were dangerous. In other words, neuroplastic pain is a false alarm.
Pain Reprocessing Therapy (PRT) is a system of psychological techniques that retrains the brain to properly interpret and respond to signals from the body, breaking the cycle of chronic pain.
Pain Reprocessing Therapy has five main components:
- Education about the brain origins and reversibility of pain,
- Gathering and reinforcing personalized evidence for the brain origins and reversibility of pain,
- Attending to and appraising pain sensations through a lens of safety,
- Addressing other emotional threats, and
- Gravitating to positive feelings and sensations.
Genetic Testing
We know the process of finding medication that works can be frustrating, time-consuming and debilitating. Fewer than 50% of individuals with depression respond to their first medication.
Genetic testing is a medical and scientific process that involves analyzing a client’s DNA to identify specific variations in their genes, chromosomes, or proteins. This testing provides a valuable information about a person’s genetic makeup and can offer into potential response to medications.
The GeneSight Psychotropic test is a genetic test that shows your provider how your genes may affect medication outcomes. The GeneSight test may reveal which medications to treat depression, anxiety, ADHD, and other mental health conditions require dose adjustments, be less likely to work, or have an increased risk of side effects based on your DNA.
The test is a simple cheek swab taken in your healthcare provider’s office or can be sent by your doctor to be taken in the convenience of your home.
Is the GeneSight test right for you?
If you are struggling with medications for mental health conditions like depression, anxiety, or ADHD, you are not alone.
Transcranial Magnetic Stimulation
TMS (Transcranial Magnetic Stimulation) is a non-invasive, outpatient treatment that uses magnetic pulses to stimulate areas of the brain that are underactive in patients with severe depression. The treatment involves placing a cushioned coil against the patient's head while magnetic pulses deliver therapy to the location that regulates mood in the brain.
A study of real-world outcomes reported an 83% response rate, which means patients experienced notable relief, and a 62% remission rate, which means their depression effectively went away.
Side effects of NeuroStar TMS include eye pain, toothache, muscle twitch, facial pain, and pain of the skin. There is also a rare risk of seizure associated with TMS therapy that occurs in less than 0.1% of people.
NeuroStar TMS is FDA-cleared for the treatment of Major Depression (MDD), obsessive-compulsive disorder (OCD), and anxious depression.
Most clients won't notice improvements after one session of TMS treatment. However, each session contributes to the recovery process. Some clients begin to see changes within one to two weeks of starting treatment, while others may wait four to five weeks.
For many, the symptoms of depression improved or disappeared within 4-6 weeks after treatment with NeuroStar. TMS therapy also managed to achieve long-term durability over 12 months.
Most patients report minimal to nonexistent side effects after TMS treatment. Some people feel more discomfort in the first few treatment sessions, and then find that reactions fade. Scalp discomfort and headaches may rarely occur.
Transcranial Magnetic Stimulation (TMS) therapy takes four to six weeks on average. Some patients see minor improvements after two weeks, while others don't notice any change until the fourth or fifth week.
Clinical trials and naturalistic studies have found that maximal therapeutic effects of rTMS treatment occur by 26–28 sessions of stimulation. For this reason, depression treatment in many clinics consists of 30 daily stimulation sessions administered over 6 weeks.
The success rate for TMS therapy ranges from 70 to 80 percent. Most patients continue to see an improvement in their symptoms for a year or longer after treatment.
